Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
Food and Drug Administration (FDA) has announced that several lots of extended-release metformin — a popular type 2 diabetes drug — contain high levels of…
By Pharmatrax Author
Category: News
No Comments
The U.S. Food and Drug Administration has issued its most serious type of recall for an imaging device that surgeons rely on during deep brain…
By Pharmatrax Author
Category: News
No Comments
On the hunt for drugs contaminated with a likely carcinogen, the FDA initially tested and cleared generic diabetes med metformin. But now, after an independent lab…
By Pharmatrax Author
Category: News
No Comments
The U.S Food and Drug Administration said on Wednesday it had found high levels of a possible cancer-causing impurity in some versions of the popular…
By Pharmatrax Author
Category: News
No Comments
U.S. regulators have asked five drugmakers whose diabetes treatments contain high levels of a chemical that can cause cancer to recall their products. The Food…
By Pharmatrax Author
Category: News
No Comments
Novartis, like many generic drugmakers, was forced to pull copies of generic Zantac off shelves late last year after a carcinogen scare shocked the industry. Now, it’s…